Skip to main content
Top
Published in: Critical Care 5/2010

Open Access 01-10-2010 | Research

Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults

Authors: Michael Adamzik, Martin Eggmann, Ulrich H Frey, Klaus Görlinger, Martina Bröcker-Preuß, Günter Marggraf, Fuat Saner, Holger Eggebrecht, Jürgen Peters, Matthias Hartmann

Published in: Critical Care | Issue 5/2010

Login to get access

Abstract

Introduction

Established biomarkers for the diagnosis of sepsis are procalcitonin, interleukin 6, and C-reactive protein. Although sepsis evokes changes of coagulation and fibrinolysis, it is unknown whether thromboelastometry can detect these alterations. We investigated whether thromboelastometry variables are suitable as biomarkers for severe sepsis in critically ill adults.

Methods

In the observational cohort study, blood samples were obtained from patients on the day of diagnosis of severe sepsis (n = 56) and from postoperative patients (n = 52), and clotting time, clot formation time, maximum clot firmness, alpha angle, and lysis index were measured with thromboelastometry. In addition, procalcitonin, interleukin 6, and C-reactive protein levels were determined. For comparison of biomarkers, receiver operating characteristic (ROC) curves were used, and the optimal cut-offs and odds ratios were calculated.

Results

In comparison with postoperative controls, patients with sepsis showed an increase in lysis index (97% ± 0.3 versus 92 ± 0.5; P < 0.001; mean and SEM) and procalcitonin (2.5 ng/ml ± 0.5 versus 30.6 ± 8.7; P < 0.001). Clot-formation time, alpha angle, maximum clot firmness, as well as interleukin 6 and C-reactive protein concentrations were not different between groups; clotting time was slightly prolonged. ROC analysis demonstrated an area under the curve (AUC) of 0.901 (CI 0.838 - 0.964) for the lysis index, and 0.756 (CI 0.666 - 0.846) for procalcitonin. The calculated cut-off for the lysis index was > 96.5%, resulting in a sensitivity of 84.2%, and a specificity of 94.2%, with an odds ratio of 85.3 (CI 21.7 - 334.5).

Conclusions

The thromboelastometry lysis index proved to be a more reliable biomarker of severe sepsis in critically ill adults than were procalcitonin, interleukin 6, and C-reactive protein. The results also demonstrate that early involvement of the hemostatic system is a common event in severe sepsis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34: 1996-2003. 10.1097/01.CCM.0000226413.54364.36CrossRefPubMed Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34: 1996-2003. 10.1097/01.CCM.0000226413.54364.36CrossRefPubMed
2.
go back to reference Bakhtiari K, Meijers JC, de Jonge E, Levi M: Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004, 32: 2416-2421. 10.1097/01.CCM.0000147769.07699.E3CrossRefPubMed Bakhtiari K, Meijers JC, de Jonge E, Levi M: Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004, 32: 2416-2421. 10.1097/01.CCM.0000147769.07699.E3CrossRefPubMed
3.
go back to reference Gando S: Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010, 38: S35-S42. 10.1097/CCM.0b013e3181c9e31dCrossRefPubMed Gando S: Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010, 38: S35-S42. 10.1097/CCM.0b013e3181c9e31dCrossRefPubMed
4.
go back to reference Ganter MT, Hofer CK: Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008, 106: 1366-1375. 10.1213/ane.0b013e318168b367CrossRefPubMed Ganter MT, Hofer CK: Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008, 106: 1366-1375. 10.1213/ane.0b013e318168b367CrossRefPubMed
5.
go back to reference Zacharowski K, Sucker C, Zacharowski P, Hartmann M: Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 2006, 95: 557-561.PubMed Zacharowski K, Sucker C, Zacharowski P, Hartmann M: Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 2006, 95: 557-561.PubMed
6.
go back to reference Velik-Salchner C, Streif W, Innerhofer P, Maier S, Knotzer H, Pajk W, Klingler A, Mittermayr M, Haas T: Endotoxinemia-induced changes in coagulation as measured by rotation thrombelastometry technique and conventional laboratory tests: results of a pilot study on pigs. Blood Coagul Fibrinolysis 2009, 20: 41-46. 10.1097/MBC.0b013e32831be9adCrossRefPubMed Velik-Salchner C, Streif W, Innerhofer P, Maier S, Knotzer H, Pajk W, Klingler A, Mittermayr M, Haas T: Endotoxinemia-induced changes in coagulation as measured by rotation thrombelastometry technique and conventional laboratory tests: results of a pilot study on pigs. Blood Coagul Fibrinolysis 2009, 20: 41-46. 10.1097/MBC.0b013e32831be9adCrossRefPubMed
7.
go back to reference Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM: : Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009, 13: R42. 10.1186/cc7765PubMedCentralCrossRefPubMed Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM: : Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009, 13: R42. 10.1186/cc7765PubMedCentralCrossRefPubMed
8.
go back to reference Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31: 1250. 2001 10.1097/01.CCM.0000050454.01978.3BCrossRefPubMed Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31: 1250. 2001 10.1097/01.CCM.0000050454.01978.3BCrossRefPubMed
9.
go back to reference Le G Jr, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRef Le G Jr, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRef
10.
go back to reference Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286: 1754-1758. 10.1001/jama.286.14.1754CrossRefPubMed Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286: 1754-1758. 10.1001/jama.286.14.1754CrossRefPubMed
11.
go back to reference Akobeng AK: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007, 96: 644-647. 10.1111/j.1651-2227.2006.00178.xCrossRefPubMed Akobeng AK: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007, 96: 644-647. 10.1111/j.1651-2227.2006.00178.xCrossRefPubMed
12.
go back to reference Ebinger T, Ruland A, Lakner M, Schwaiger M: Validity, regulatory registration and approval of ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2010, 21: 106-107. 10.1097/MBC.0b013e3283306e28CrossRefPubMed Ebinger T, Ruland A, Lakner M, Schwaiger M: Validity, regulatory registration and approval of ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2010, 21: 106-107. 10.1097/MBC.0b013e3283306e28CrossRefPubMed
13.
go back to reference Gillies BS: Thromboelastography and liver transplantation. Semin Thromb Hemost 1995,21(Suppl 4):45-49.PubMed Gillies BS: Thromboelastography and liver transplantation. Semin Thromb Hemost 1995,21(Suppl 4):45-49.PubMed
14.
go back to reference Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA, EACTS Audit and Guidelines Committee: Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008, 34: 73-92. 10.1016/j.ejcts.2008.02.024CrossRefPubMed Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA, EACTS Audit and Guidelines Committee: Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008, 34: 73-92. 10.1016/j.ejcts.2008.02.024CrossRefPubMed
15.
go back to reference Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC: Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006, 10: R160. 10.1186/cc5098PubMedCentralCrossRefPubMed Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC: Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006, 10: R160. 10.1186/cc5098PubMedCentralCrossRefPubMed
16.
go back to reference Levi M, van der Poll T: Inflammation and coagulation. Crit Care Med 2010, 38: S26-S34. 10.1097/CCM.0b013e3181c98d21CrossRefPubMed Levi M, van der Poll T: Inflammation and coagulation. Crit Care Med 2010, 38: S26-S34. 10.1097/CCM.0b013e3181c98d21CrossRefPubMed
17.
go back to reference Boudjeltia KZ, Ollieuz S, Piagnerelli M, Biston P, Cauchie P, Vincent JL, Brohee D, Vanhaeverbeek M: Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand factor in critically ill patients. Thromb J 2009, 7: 10.PubMedCentralCrossRefPubMed Boudjeltia KZ, Ollieuz S, Piagnerelli M, Biston P, Cauchie P, Vincent JL, Brohee D, Vanhaeverbeek M: Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand factor in critically ill patients. Thromb J 2009, 7: 10.PubMedCentralCrossRefPubMed
18.
go back to reference van der Poll T, Levi M, Büller HR, van Deventer SJ, de Boer JP, Hack CE, ten Cate JW: Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991, 174: 729-732. 10.1084/jem.174.3.729CrossRefPubMed van der Poll T, Levi M, Büller HR, van Deventer SJ, de Boer JP, Hack CE, ten Cate JW: Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991, 174: 729-732. 10.1084/jem.174.3.729CrossRefPubMed
19.
go back to reference Neyrinck AP, Liu KD, Howard JP, Matthay MA: Protective mechanisms of activated protein C in severe inflammatory disorders. Br J Pharmacol 2009, 158: 1034-1047. 10.1111/j.1476-5381.2009.00251.xPubMedCentralCrossRefPubMed Neyrinck AP, Liu KD, Howard JP, Matthay MA: Protective mechanisms of activated protein C in severe inflammatory disorders. Br J Pharmacol 2009, 158: 1034-1047. 10.1111/j.1476-5381.2009.00251.xPubMedCentralCrossRefPubMed
20.
go back to reference Mosnier LO, Meijers JC, Bouma BN: Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001, 85: 5-11.PubMed Mosnier LO, Meijers JC, Bouma BN: Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001, 85: 5-11.PubMed
21.
go back to reference Savioli M, Cugno M, Polli F, Taccone P, Bellani G, Spanu P, Pesenti A, Iapichino G, Gattinoni L: Tight glycemic control may favor fibrinolysis in patients with sepsis. Crit Care Med 2009, 37: 424-431. 10.1097/CCM.0b013e31819542daCrossRefPubMed Savioli M, Cugno M, Polli F, Taccone P, Bellani G, Spanu P, Pesenti A, Iapichino G, Gattinoni L: Tight glycemic control may favor fibrinolysis in patients with sepsis. Crit Care Med 2009, 37: 424-431. 10.1097/CCM.0b013e31819542daCrossRefPubMed
22.
go back to reference Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen-activator gene-function in mice. Nature 1994, 368: 419-424. 10.1038/368419a0CrossRefPubMed Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen-activator gene-function in mice. Nature 1994, 368: 419-424. 10.1038/368419a0CrossRefPubMed
23.
go back to reference Sun H, Wang X, Degen JL, Ginsburg D: Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 2009, 113: 1358-1364. 10.1182/blood-2008-07-170506PubMedCentralCrossRefPubMed Sun H, Wang X, Degen JL, Ginsburg D: Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 2009, 113: 1358-1364. 10.1182/blood-2008-07-170506PubMedCentralCrossRefPubMed
Metadata
Title
Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults
Authors
Michael Adamzik
Martin Eggmann
Ulrich H Frey
Klaus Görlinger
Martina Bröcker-Preuß
Günter Marggraf
Fuat Saner
Holger Eggebrecht
Jürgen Peters
Matthias Hartmann
Publication date
01-10-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9284

Other articles of this Issue 5/2010

Critical Care 5/2010 Go to the issue